Microchimerism in Patients With Recurrent Pregnancy Losses
Primary Purpose
Recurrent Pregnancy Loss, Not Pregnant
Status
Recruiting
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
Blood sample
Swap test
Sponsored by
About this trial
This is an interventional basic science trial for Recurrent Pregnancy Loss, Not Pregnant
Eligibility Criteria
sRPL patient (proband):
Inclusion Criteria:
- ≥3 consecutive pregnancy losses ≤12 weeks of gestation, which do not include confirmed ectopic or molar pregnancies.
- Age <41 years at time of admission
- Patients who have minimum one alive older brother with a common mother and prior birth of a boy, and patients who have minimum one alive older brother with a common mother and prior birth of a girl.
Exclusion Criteria:
- Significant intrauterine malformations
- Thyroid dysfunction
- Known chromosomal abnormality
- An older brother, a son or a daughter from whom we cannot not collect a swab test e.g., due to lack of consent, death, distance etc.
- Transplant recipient
- Transfusion recipient
- Pregnancy at the time the blood sample is collected
Older Brother:
Inclusion Criteria:
- Age difference between proband and the older brother <15 years
- Common mother with the proband
sRPL patient's child:
Inclusion Criteria:
- Age <15 years
Sites / Locations
- Aalborg University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
sRPL patient
Brother or child to the sRPL patient
Arm Description
sRPL with an older brother and at least one child prior to diagnosis
An older brother (with at least same biological mother) og child to the sRPL patient
Outcomes
Primary Outcome Measures
Frequency of sRPL patients with microchimeric male cells
Prevalence of sRPL patients with microchimeric male cells in the peripheral blood
Frequency of sRPL patients with microchimeric cell originating from older brother
Determination of microchimeric cell origin: brother, son, daughter or not identified
Frequency of sRPL patients with microchimeric cell originating from the patient's son
Determination of microchimeric cell origin: brother, son, daughter or not identified
Frequency of sRPL patients with microchimeric cell originating from the patient's daughter
Determination of microchimeric cell origin: brother, son, daughter or not identified
Frequency of sRPL patients with microchimeric cell originating from unknown person
Determination of microchimeric cell origin: brother, son, daughter or not identified
Secondary Outcome Measures
Full Information
NCT ID
NCT05340556
First Posted
April 8, 2022
Last Updated
April 15, 2022
Sponsor
Caroline Nørgaard-Pedersen
Collaborators
Department of Clinical Immunology, Odense University Hospital, DK, Department of Clinical Immunology at Aalborg University Hospital, Northern DK
1. Study Identification
Unique Protocol Identification Number
NCT05340556
Brief Title
Microchimerism in Patients With Recurrent Pregnancy Losses
Official Title
Microchimerism From a Firstborn Boy or an Older Brother in Patients With Recurrent Pregnancy Losses: a Pilot Study
Study Type
Interventional
2. Study Status
Record Verification Date
April 2022
Overall Recruitment Status
Recruiting
Study Start Date
April 1, 2022 (Actual)
Primary Completion Date
January 1, 2023 (Anticipated)
Study Completion Date
January 1, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Caroline Nørgaard-Pedersen
Collaborators
Department of Clinical Immunology, Odense University Hospital, DK, Department of Clinical Immunology at Aalborg University Hospital, Northern DK
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This pilot study aims to evaluate if microchimeric cells in a patient with recurrent pregnancy loss (RPL) can be detected by the blood analysis for the presence of the DYS14 gene and the use of indel-panel methods and also, to examine if this method can distinguish the cell's origin; comparing gene sequence from the patient's firstborn son or her older brother. In addition, the pilot study will provide the investigators with information and experience necessary for a subsequent main study to be conducted.
Detailed Description
To the investigators' knowledge, no previous study has determined the origin of microchimeric cells, and therefore, this pilot study will use a newly developed genetic analysis which will compare DNA fragments from the male microchimeric cells with DNA fragments from the RPL patient's son(s) and older brother(s).
The pilot study aims to evaluate the functions and capacity of a newly developed genetic test identifying microchimeric cells. A pilot study is necessary to assure the DNA fragments (indels) analyzed in the genetic analysis include enough informative differences to distinguish between the son(s), daughter(s) and the older brother(s) before these investigations can be initiated in a larger sample. To assure the test can distinguish origin of microchimeric cells between relatives and work independent of gender, The study will include both the proband's daughter(s) and son(s) to strengthen the confidence that the test possesses this ability.
10 sRPL and their older brother(s) and firstborn child is included. total included: approx 30.
Only sRPL whose brother(s) and child(ren) also consent to participate, will be included.
Blood sample of 12 ml EDTA plasma is collected from the sRPL patient. A swap sample from oral mucosa is collected from the older brother and child(ren).
The samples will be centrifuged and the buffy coat containing the DNA will be collected from patient and stored at -80 °C. To detect the multi-copy DYS14 marker located in the TSPY1 gene on the Y-chromosome a real-time PCR analysis will be performed on the extracted DNA with a PCR mastermix specific for the reference gene.
Also, The extracted DNA will be amplified using specific primers and their associated probes in a multiplex PCR analysis. The specific primers target the 10 different indels leading to 10 PCR products with non-overlapping amplicon sizes. After the PCR analyses, the fragments are analyzed by capillary electrophoresis using GeneticAnalyzer and GeneMapper. When differences are identified, a qPCR analysis is performed on samples from only the proband with primers and probes specific for the indel fragments that are only present in either the child or the older brother. 12 wells loaded with 30.000 GE in each well are screened along with a no-template control and a positive control containing 10 GE of DNA homozygous for the allele variant.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Recurrent Pregnancy Loss, Not Pregnant
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
30 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
sRPL patient
Arm Type
Experimental
Arm Description
sRPL with an older brother and at least one child prior to diagnosis
Arm Title
Brother or child to the sRPL patient
Arm Type
Experimental
Arm Description
An older brother (with at least same biological mother) og child to the sRPL patient
Intervention Type
Genetic
Intervention Name(s)
Blood sample
Intervention Description
Blood sample of 12 ml EDTA plasma.
Intervention Type
Genetic
Intervention Name(s)
Swap test
Intervention Description
receive swab tests for collecting cells from the oral mucosa
Primary Outcome Measure Information:
Title
Frequency of sRPL patients with microchimeric male cells
Description
Prevalence of sRPL patients with microchimeric male cells in the peripheral blood
Time Frame
Non-pregnant state, performed during study completion, i.e. within 1 year
Title
Frequency of sRPL patients with microchimeric cell originating from older brother
Description
Determination of microchimeric cell origin: brother, son, daughter or not identified
Time Frame
Non-pregnant state, performed during study completion, i.e. within 1 year
Title
Frequency of sRPL patients with microchimeric cell originating from the patient's son
Description
Determination of microchimeric cell origin: brother, son, daughter or not identified
Time Frame
Non-pregnant state, performed during study completion, i.e. within 1 year
Title
Frequency of sRPL patients with microchimeric cell originating from the patient's daughter
Description
Determination of microchimeric cell origin: brother, son, daughter or not identified
Time Frame
Non-pregnant state, performed during study completion, i.e. within 1 year
Title
Frequency of sRPL patients with microchimeric cell originating from unknown person
Description
Determination of microchimeric cell origin: brother, son, daughter or not identified
Time Frame
Non-pregnant state, performed during study completion, i.e. within 1 year
10. Eligibility
Sex
All
Gender Based
Yes
Gender Eligibility Description
sRPL patient: women. Sibling: Older brother to sRPL patient. Child: The sRPL patient's child(ren) of both sexes. Biological sex is used.
Accepts Healthy Volunteers
No
Eligibility Criteria
sRPL patient (proband):
Inclusion Criteria:
≥3 consecutive pregnancy losses ≤12 weeks of gestation, which do not include confirmed ectopic or molar pregnancies.
Age <41 years at time of admission
Patients who have minimum one alive older brother with a common mother and prior birth of a boy, and patients who have minimum one alive older brother with a common mother and prior birth of a girl.
Exclusion Criteria:
Significant intrauterine malformations
Thyroid dysfunction
Known chromosomal abnormality
An older brother, a son or a daughter from whom we cannot not collect a swab test e.g., due to lack of consent, death, distance etc.
Transplant recipient
Transfusion recipient
Pregnancy at the time the blood sample is collected
Older Brother:
Inclusion Criteria:
Age difference between proband and the older brother <15 years
Common mother with the proband
sRPL patient's child:
Inclusion Criteria:
Age <15 years
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Caroline Noergaard-Pedersen, MD
Phone
+4541120267
Email
c.noergaardpedersen@rn.dk
First Name & Middle Initial & Last Name or Official Title & Degree
Ole Bjarne Christiansen, professor
Phone
41120267
Email
olbc@rn.dk
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Caroline Nørgaard-Pedersen, MD
Organizational Affiliation
Aalborg University Hospital, Denmark
Official's Role
Principal Investigator
Facility Information:
Facility Name
Aalborg University Hospital
City
Aalborg
ZIP/Postal Code
9000
Country
Denmark
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Caroline Nørgaard-Pedersen
Phone
41120267
Email
c.noergaardpedersen@rn.dk
12. IPD Sharing Statement
Learn more about this trial
Microchimerism in Patients With Recurrent Pregnancy Losses
We'll reach out to this number within 24 hrs